查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1684460

大肠直肠筛检市场：全球产业分析、市场规模、份额、成长、趋势和未来预测（2025-2032）

Colon Screening Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 181 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 最近发布了一份关于全球大肠直肠筛检市场的综合报告。该报告对市场驱动因素、趋势、机会、驱动因素和挑战等关键市场动态进行了全面评估，并对市场结构提供了详细的见解。本研究报告提供独家资料和统计数据，概述了 2025 年至 2032 年全球结直肠筛检市场的预期成长轨迹。

关键见解

  • 大肠直肠筛检市场规模（2025年）：187亿美元
  • 市场规模预测（以金额为准，2032年）：244.5亿美元
  • 全球市场成长率（2025-2032年复合年增长率）：3.9%

大肠直肠筛检市场：分析范围

大肠筛检在结肠癌的早期发现和预防中起着重要作用。大肠镜检查、粪便检查和影像技术等筛检方法有助于识别癌前息肉和早期恶性肿瘤，显着改善患者的预后。大肠直肠筛检市场服务于医院、诊断检测中心、门诊手术中心和家庭医疗保健机构，提供各种筛检技术，包括粪便免疫化学检查(FIT)、粪便 DNA 检测、乙状结肠镜检查和 CT 结肠造影。市场成长的动力包括结直肠癌盛行率的上升、人们对早期发现益处的认识不断提高以及筛检技术的进步提高了准确性和可及性。

市场成长动力：

全球大肠直肠筛检市场受到几个关键因素的推动，包括饮食习惯的改变、人口老化以及久坐生活方式导致的大肠癌负担的增加。政府推广的定期筛检计划和优惠的报销政策将进一步加速市场扩张。人工智慧 (AI) 辅助大肠镜检查、液态切片测试和非侵入性筛检解决方案等技术进步将提高诊断准确性和患者依从性。此外，套件的日益普及为市场成长套件了新的途径，特别是在医疗设施有限的地区。

市场限制：

儘管成长前景看好，但结直肠筛检市场面临着高检测成本、低收入地区筛检机会有限以及患者因侵入性检测方法而不愿接受筛检等挑战。此外，新筛检技术的监管障碍和严格的核准流程也对製造商进入市场构成了障碍。此外，不同人口群体的意识和筛检接受度的差异也影响整体市场渗透率。应对这些挑战需要医疗保健提供者、政府和行业相关人员的共同努力，以提高筛检的可负担性、教育性和可近性。

市场机会：

在技​​术创新、策略伙伴关係和不断扩大的医疗保健基础设施的推动下，结直肠筛检市场提供了巨大的成长机会。人工智慧在诊断成像中的整合、用于非侵入性早期检测的液态切片的开发以及家庭筛检套件的进步正在为市场参与者开闢新的领域。远端医疗和数位健康平台可以进一步促进患者参与和后续护理，提高筛检依从性。此外，对癌症研究和早期检测倡议的资金增加为产品开发和市场发展创造了有利的环境。投资于具有成本效益且准确的筛选解决方案的公司将在这个不断发展的市场中获得竞争优势。

本报告回答的关键问题

  • 推动全球大肠直肠筛检市场成长的关键因素有哪些？
  • 哪些筛检技术和方法在不同的医疗保健环境中获得最多支援？
  • 科技进步如何改变大肠直肠筛检市场的竞争格局？
  • 哪些主要企业正在为大肠直肠筛检市场做出贡献？他们采用什么策略来维持市场相关性？
  • 全球大肠直肠筛检市场的新兴趋势和未来前景如何？

目录

第一章执行摘要

第二章 市场概述

  • 市场范围和定义
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
    • 任务
    • 主要趋势
  • 宏观经济因素
    • 全球产业展望
    • 全球GDP成长前景
  • COVID-19影响分析
  • 预测因子：相关性和影响力

第三章 增值洞察

  • 监管状况
  • 产品采用分析
  • 价值链分析
  • 重大交易及合併
  • PESTLE分析
  • 波特五力分析

第四章全球大肠直肠筛检市场展望

  • 主要亮点
    • 市场规模及与前一年同期比较率（十亿美元）
    • 绝对的商机
  • 市场规模分析及预测（十亿美元）
    • 历史市场规模分析（十亿美元，2019-2024）
    • 当前市场规模分析与预测（十亿美元，2025-2032）
  • 全球大肠直肠筛检市场展望（按筛检类型）
    • 简介/主要发现
    • 按筛检类型分類的历史市场规模分析（十亿美元，2019-2024 年）
    • 按筛检类型分類的当前市场规模分析和预测（十亿美元，2025 年至 2032 年）
      • 粪便检验
        • 粪便免疫化学检查（FIT）
        • 癒创木酚大便潜血试验（gFOBT）
        • 其他的
      • 大肠镜检查
      • 柔性乙状结肠镜检查
      • 胶囊内视镜检查
      • 其他的
    • 依筛检类型进行市场吸引力分析
  • 全球大肠直肠筛检市场展望（依产品类型）
    • 简介/主要发现
    • 按产品类型分類的历史市场规模分析（十亿美元，2019-2024 年）
    • 目前市场规模分析及依产品类型预测（十亿美元，2025-2032）
      • 内视镜检查
      • CT扫描仪
      • 胶囊内视镜检查
      • 检测套件和试剂
      • 其他的
    • 市场吸引力分析：按产品类型
  • 全球大肠直肠筛检市场前景（按最终用户）
    • 简介/主要发现
    • 按最终用户分類的历史市场规模分析（十亿美元，2019-2024 年）
    • 目前市场规模分析及最终用户预测（十亿美元，2025-2032）
      • 医院
      • 诊断和影像中心
      • 研究和学术机构
      • 其他的
    • 最终用户的市场吸引力分析

5. 全球大肠直肠筛检市场（按地区）展望

  • 主要亮点
  • 按地区分類的历史市场规模分析（十亿美元，2019-2024 年）
  • 目前市场规模分析及各地区预测（十亿美元，2025-2032）
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

6. 北美大肠直肠筛检市场展望

7. 欧洲大肠直肠筛检市场展望

第八章东亚结直肠筛检市场展望

9. 南亚和大洋洲结直肠筛检市场展望

10. 拉丁美洲结直肠筛检市场展望

第 11 章中东和非洲结直肠筛检市场展望

第十二章竞争格局

  • 市场占有率分析（2025年）
  • 市场结构
    • 竞争强度图：按市场
    • 竞争仪錶板
  • 公司简介（详情：概述、财务状况、策略、最新发展）
    • Olympus Corporation
    • PENTAX Medical（Hoya Corporation）
    • FUJIFILM Holdings Corporation
    • Medtronic
    • Ambu A/S
    • Baxter（Hillrom &Welch Allyn）
    • EndoFresh
    • （Daichuan medical）
    • Bracco
    • Varay Laborix
    • QuidelOrtho Corporation
    • Novigenix SA
    • Guardant Health, Inc.
    • Mainz Biomed NV
    • Eiken Chemical Co., Ltd.

第十三章 附录

  • 分析方法
  • 分析前提条件
  • 首字母缩写和简称
简介目录
Product Code: PMRREP35162

Persistence Market Research has recently released a comprehensive report on the worldwide market for colon screening. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global colon screening market from 2025 to 2032.

Key Insights:

  • Colon Screening Market Size (2025E): US$ 18.7 Bn
  • Projected Market Value (2032F): US$ 24.45 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 3.9%

Colon Screening Market - Report Scope:

Colon screening plays a crucial role in the early detection and prevention of colorectal cancer, one of the leading causes of cancer-related deaths worldwide. Screening methods such as colonoscopy, stool-based tests, and imaging techniques help identify precancerous polyps and early-stage malignancies, significantly improving patient outcomes. The colon screening market serves hospitals, diagnostic laboratories, ambulatory surgical centers, and home healthcare settings, offering a range of screening technologies, including fecal immunochemical tests (FIT), stool DNA tests, sigmoidoscopy, and CT colonography. Market growth is driven by the rising prevalence of colorectal cancer, increasing awareness of early detection benefits, and advancements in screening technologies that enhance accuracy and accessibility.

Market Growth Drivers:

The global colon screening market is propelled by several key factors, including the growing burden of colorectal cancer due to changing dietary habits, aging populations, and sedentary lifestyles. Government initiatives promoting routine screening programs and favorable reimbursement policies further accelerate market expansion. Technological advancements, such as artificial intelligence (AI)-assisted colonoscopy, liquid biopsy tests, and non-invasive screening solutions, enhance diagnostic precision and patient compliance. Additionally, the increasing adoption of home-based and self-administered screening kits provides new avenues for market growth, particularly in regions with limited access to healthcare facilities.

Market Restraints:

Despite promising growth prospects, the colon screening market faces challenges related to high procedure costs, limited access to screening in low-income regions, and patient reluctance due to invasive test methods. Regulatory hurdles and stringent approval processes for new screening technologies also pose market entry barriers for manufacturers. Furthermore, disparities in awareness and screening adherence rates across different demographic groups impact overall market penetration. Addressing these challenges requires collaborative efforts from healthcare providers, governments, and industry stakeholders to enhance screening affordability, education, and accessibility.

Market Opportunities:

The colon screening market presents significant growth opportunities driven by technological innovations, strategic partnerships, and expanding healthcare infrastructure. The integration of AI in diagnostic imaging, liquid biopsy development for non-invasive early detection, and advancements in at-home screening kits open new frontiers for market players. Telemedicine and digital health platforms further facilitate patient engagement and follow-up care, improving screening adherence rates. Additionally, increased funding for cancer research and early detection initiatives creates a favorable landscape for product development and market expansion. Companies investing in cost-effective, high-accuracy screening solutions stand to gain a competitive advantage in this evolving market.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the colon screening market globally?
  • Which screening technologies and methods are gaining the most traction across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the colon screening market?
  • Who are the key players contributing to the colon screening market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global colon screening market?

Competitive Intelligence and Business Strategy:

Leading players in the global colon screening market, including Exact Sciences Corporation, Abbott Laboratories, Siemens Healthineers, and Olympus Corporation, focus on innovation, regulatory approvals, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop next-generation screening technologies, such as AI-driven colonoscopy tools, liquid biopsy solutions, and enhanced stool-based tests, catering to diverse patient needs. Partnerships with healthcare providers, insurance companies, and diagnostic laboratories facilitate market access and promote screening adoption. Additionally, initiatives aimed at increasing patient awareness, physician training, and government collaborations further strengthen market penetration.

Key Companies Profiled:

  • Exact Sciences Corporation
  • Abbott Laboratories
  • Siemens Healthineers
  • Olympus Corporation
  • Medtronic Plc
  • Quest Diagnostics Incorporated
  • Epigenomics AG
  • Natera, Inc.
  • Guardant Health, Inc.
  • Eiken Chemical Co., Ltd.

Colon Screening Industry Segmentation

By Screening Type

  • Stool-Based Tests
  • Colonoscopy
  • Flexible Sigmoidoscopy
  • Capsule Endoscopy

By Product Type

  • Endoscopes
  • CT Scanners
  • Capsule Endoscopes
  • Test Kits & Reagents

By End User

  • Hopitals
  • Diagnostic & Imaging Centers
  • Research & Academic Institutions

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Middle East and Africa
  • Latin America

Table of Contents

1. Executive Summary

  • 1.1. Global Colon Screening Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Regulatory Landscape
  • 3.2. Product Adoption Analysis
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Global Colon Screening Market Outlook:

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 4.3. Global Colon Screening Market Outlook: Screening Type
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Screening Type,2019-2024
    • 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Screening Type, 2025-2032
      • 4.3.3.1. Stool-Based Tests
        • 4.3.3.1.1. Fecal Immunochemical Test (FIT)
        • 4.3.3.1.2. Guaiac-Based Fecal Occult Blood Test (gFOBT)
        • 4.3.3.1.3. Others
      • 4.3.3.2. Colonoscopy
      • 4.3.3.3. Flexible Sigmoidoscopy
      • 4.3.3.4. Capsule Endoscopy
      • 4.3.3.5. Others
    • 4.3.4. Market Attractiveness Analysis: Screening Type
  • 4.4. Global Colon Screening Market Outlook: Product Type
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Bn) Analysis, By Product Type,2019-2024
    • 4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
      • 4.4.3.1. Endoscopes
      • 4.4.3.2. CT Scanners
      • 4.4.3.3. Capsule Endoscopes
      • 4.4.3.4. Test Kits & Reagents
      • 4.4.3.5. Others
    • 4.4.4. Market Attractiveness Analysis: Product Type
  • 4.5. Global Colon Screening Market Outlook: End User
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Bn) Analysis, By End User,2019-2024
    • 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
      • 4.5.3.1. Hospitals
      • 4.5.3.2. Diagnostic & Imaging Centers
      • 4.5.3.3. Research & Academic Institutions
      • 4.5.3.4. Others
    • 4.5.4. Market Attractiveness Analysis: End User

5. Global Colon Screening Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis, By Region,2019-2024
  • 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Colon Screening Market Outlook:

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Market,2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Screening Type
    • 6.2.3. By Product Type
    • 6.2.4. By End User
  • 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Screening Type, 2025-2032
    • 6.4.1. Stool-Based Tests
      • 6.4.1.1. Fecal Immunochemical Test (FIT)
      • 6.4.1.2. Guaiac-Based Fecal Occult Blood Test (gFOBT)
      • 6.4.1.3. Others
    • 6.4.2. Colonoscopy
    • 6.4.3. Flexible Sigmoidoscopy
    • 6.4.4. Capsule Endoscopy
    • 6.4.5. Others
  • 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 6.5.1. Endoscopes
    • 6.5.2. CT Scanners
    • 6.5.3. Capsule Endoscopes
    • 6.5.4. Test Kits & Reagents
    • 6.5.5. Others
  • 6.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 6.6.1. Hospitals
    • 6.6.2. Diagnostic & Imaging Centers
    • 6.6.3. Research & Academic Institutions
    • 6.6.4. Others
  • 6.7. Market Attractiveness Analysis

7. Europe Colon Screening Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market,2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Screening Type
    • 7.2.3. By Product Type
    • 7.2.4. By End User
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Screening Type, 2025-2032
    • 7.4.1. Stool-Based Tests
      • 7.4.1.1. Fecal Immunochemical Test (FIT)
      • 7.4.1.2. Guaiac-Based Fecal Occult Blood Test (gFOBT)
      • 7.4.1.3. Others
    • 7.4.2. Colonoscopy
    • 7.4.3. Flexible Sigmoidoscopy
    • 7.4.4. Capsule Endoscopy
    • 7.4.5. Others
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 7.5.1. Endoscopes
    • 7.5.2. CT Scanners
    • 7.5.3. Capsule Endoscopes
    • 7.5.4. Test Kits & Reagents
    • 7.5.5. Others
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 7.6.1. Hospitals
    • 7.6.2. Diagnostic & Imaging Centers
    • 7.6.3. Research & Academic Institutions
    • 7.6.4. Others
  • 7.7. Market Attractiveness Analysis

8. East Asia Colon Screening Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market,2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Screening Type
    • 8.2.3. By Product Type
    • 8.2.4. By End User
  • 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Screening Type, 2025-2032
    • 8.4.1. Stool-Based Tests
      • 8.4.1.1. Fecal Immunochemical Test (FIT)
      • 8.4.1.2. Guaiac-Based Fecal Occult Blood Test (gFOBT)
      • 8.4.1.3. Others
    • 8.4.2. Colonoscopy
    • 8.4.3. Flexible Sigmoidoscopy
    • 8.4.4. Capsule Endoscopy
    • 8.4.5. Others
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 8.5.1. Endoscopes
    • 8.5.2. CT Scanners
    • 8.5.3. Capsule Endoscopes
    • 8.5.4. Test Kits & Reagents
    • 8.5.5. Others
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 8.6.1. Hospitals
    • 8.6.2. Diagnostic & Imaging Centers
    • 8.6.3. Research & Academic Institutions
    • 8.6.4. Others
  • 8.7. Market Attractiveness Analysis

9. South Asia & Oceania Colon Screening Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market,2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Screening Type
    • 9.2.3. By Product Type
    • 9.2.4. By End User
  • 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Screening Type, 2025-2032
    • 9.4.1. Stool-Based Tests
      • 9.4.1.1. Fecal Immunochemical Test (FIT)
      • 9.4.1.2. Guaiac-Based Fecal Occult Blood Test (gFOBT)
      • 9.4.1.3. Others
    • 9.4.2. Colonoscopy
    • 9.4.3. Flexible Sigmoidoscopy
    • 9.4.4. Capsule Endoscopy
    • 9.4.5. Others
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 9.5.1. Endoscopes
    • 9.5.2. CT Scanners
    • 9.5.3. Capsule Endoscopes
    • 9.5.4. Test Kits & Reagents
    • 9.5.5. Others
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 9.6.1. Hospitals
    • 9.6.2. Diagnostic & Imaging Centers
    • 9.6.3. Research & Academic Institutions
    • 9.6.4. Others
  • 9.7. Market Attractiveness Analysis

10. Latin America Colon Screening Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market,2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Screening Type
    • 10.2.3. By Product Type
    • 10.2.4. By End User
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Screening Type, 2025-2032
    • 10.4.1. Stool-Based Tests
      • 10.4.1.1. Fecal Immunochemical Test (FIT)
      • 10.4.1.2. Guaiac-Based Fecal Occult Blood Test (gFOBT)
      • 10.4.1.3. Others
    • 10.4.2. Colonoscopy
    • 10.4.3. Flexible Sigmoidoscopy
    • 10.4.4. Capsule Endoscopy
    • 10.4.5. Others
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 10.5.1. Endoscopes
    • 10.5.2. CT Scanners
    • 10.5.3. Capsule Endoscopes
    • 10.5.4. Test Kits & Reagents
    • 10.5.5. Others
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 10.6.1. Hospitals
    • 10.6.2. Diagnostic & Imaging Centers
    • 10.6.3. Research & Academic Institutions
    • 10.6.4. Others
  • 10.7. Market Attractiveness Analysis

11. Middle East & Africa Colon Screening Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market,2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Screening Type
    • 11.2.3. By Product Type
    • 11.2.4. By End User
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Screening Type, 2025-2032
    • 11.4.1. Stool-Based Tests
      • 11.4.1.1. Fecal Immunochemical Test (FIT)
      • 11.4.1.2. Guaiac-Based Fecal Occult Blood Test (gFOBT)
      • 11.4.1.3. Others
    • 11.4.2. Colonoscopy
    • 11.4.3. Flexible Sigmoidoscopy
    • 11.4.4. Capsule Endoscopy
    • 11.4.5. Others
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 11.5.1. Endoscopes
    • 11.5.2. CT Scanners
    • 11.5.3. Capsule Endoscopes
    • 11.5.4. Test Kits & Reagents
    • 11.5.5. Others
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 11.6.1. Hospitals
    • 11.6.2. Diagnostic & Imaging Centers
    • 11.6.3. Research & Academic Institutions
    • 11.6.4. Others
  • 11.7. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Olympus Corporation
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. PENTAX Medical (Hoya Corporation)
    • 12.3.3. FUJIFILM Holdings Corporation
    • 12.3.4. Medtronic
    • 12.3.5. Ambu A/S
    • 12.3.6. Baxter (Hillrom & Welch Allyn)
    • 12.3.7. EndoFresh
    • 12.3.8. (Daichuan medical)
    • 12.3.9. Bracco
    • 12.3.10. Varay Laborix
    • 12.3.11. QuidelOrtho Corporation
    • 12.3.12. Novigenix SA
    • 12.3.13. Guardant Health, Inc.
    • 12.3.14. Mainz Biomed N.V.
    • 12.3.15. Eiken Chemical Co., Ltd.

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations